Fox Chase Cancer Center News

PHILADELPHIA (February 10, 2022)—Johnathan R. Whetstine, PhD, director of the Cancer Epigenetics Institute at Fox Chase Cancer Center, was recently honored with a Maximizing Investigators’ Research Award (MIRA) from the National Institute of General Medical Sciences (NIGMS). This five-year grant will fund fundamental research on DNA amplification and uncovering pathways that control it.

PHILADELPHIA (February 7, 2022)—According to a new study from researchers at Fox Chase Cancer Center, mRNA vaccine for COVID-19 is just as safe for people with cancer as it is for cancer-free individuals.

PHILADELPHIA (February 3, 2022)—Linda Fleisher, PhD, MPH, associate research professor in the Cancer Prevention and Control research program at Fox Chase Cancer Center, was recently recognized with the Lillie D. Shockney Lifetime Achievement Award from the Academy of Oncology Nurse & Patient Navigators (AONN+).

PHILADELPHIA (February 1, 2022)—Patients recovering from COVID-19 who continue to have certain debilitating symptoms such as chronic fatigue may need long-term support, including evaluation of the endocrine system, according to a recent review.

PHILADELPHIA (February 1, 2022)—In a recent study, researchers at Fox Chase Cancer Center found that gene therapy using a genetically engineered viral vector was highly effective in treating cystathionine β-synthase deficiency (CBS) in mice.

PHILADELPHIA (January 31, 2022)—Margaret von Mehren, MD, chief of the Division of Sarcoma Medical Oncology at Fox Chase Cancer Center, was recently appointed the new vice chair of the Department of Hematology/Oncology.

PHILADELPHIA (January 31, 2022)—Iberia Romina Sosa, MD, PhD, an associate professor at Fox Chase Cancer Center, was recently appointed the new chief of the Division of Hematology in the Department of Hematology/Oncology.

PHILADELPHIA (January 27, 2022)—Laura Bukavina, MD, MPH, a Urologic Oncology Fellow at Fox Chase Cancer Center, has been awarded the American Society of Clinical Oncology (ASCO) Genitourinary Conquer Cancer Merit Award. She will present the winning abstract, which characterizes the gut microbiome of bladder cancer patients, at the 2022 ASCO Genitourinary Cancers Symposium in San Francisco, which is being held February 17-19.